新医改背景下加强公立医院药品进销存精细化管理的意义——以ZY医院为例  

The Significance of Strengthening the Fine Management of Drug Purchase,Sale and Stock in Public Hospitals under the Background of New Medical Reform--Take ZY Hospital as An Example

作  者:康学英 KANG Xue-Ying(Accounting Department of Traditional Chinese Medicine Hospital of Inner Mongolia Autonomous Region,Hohhot O10010,China)

机构地区:[1]内蒙古自治区中医医院财务部,呼和浩特010010

出  处:《中国药物经济学》2025年第1期114-116,120,共4页China Journal of Pharmaceutical Economics

摘  要:药品是医疗服务工作中不可或缺的重要物资,取消药品加成政策后,医院的收入结构发生了重大变化,对药品进行精细化管理具有重要意义。本文阐述了公立医院药品管理现状和存在的问题,提出了强化药品采购预算、加强过程监管、优化工作流程和盘点清查制度等措施,以控制经营管理风险,降低药品成本,从而为公立医院加强药品核算与管理提供新的参考思路。Medicine is an important material in medical service.Drug cancellation policy has caused significant changes in the income structure of hospitals.The fine management of drugs is of great significance for the benefit of management.This paper expounds the current situation and existing problems of drug management in public hospitals,and puts forward measures such as strengthening drug procurement budget,strengthening process supervision,optimizing work flow and inventory system to control operation and management risks and reduce drug costs,so as to provide new reference ideas for strengthening drug accounting and management in public hospitals.

关 键 词:新医改 药品进销存 精细化管理 

分 类 号:R954[医药卫生—药学]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象